NCOG-24. REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA IN BRITISH COLUMBIA
Authors: Manik Chahal, Brian Thiessen
Published: 2021-11-18
DOI:
10.1093/neuonc/noab196.615
Source:
Full article
Abstract
Abstract